Articles

2006-2007 Influenza Resources for Healthcare Professionals [PDF]
Malatestinic W, Braun L, Jorgenson JA et al. Components of Medicare reimbursement. Am J Health-Syst Pharm. 2003;60(suppl 6):3-7.
Mitchell CL, Anderson ER, Braun L. Billing for inpatient hospital care. Am J Health-Syst Pharm. 2003;60 (suppl 6):8-11.
Alexander S, Conner T, Slaughter T. Overview of inpatient coding. Am J Health-Syst Pharm. 2003;60(Suppl 6):11-14.
Meyer BM and Cantwell KM. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003: Implications for health-system pharmacy. Am J Health-Syst Pharm. 2004;61:1042- 51.
Summary of the Executive Sessions on Medication Therapy Management Programs. Am J Health-Syst Pharm. 2005;62:585-92.
Okafor MC. Pharmacy implications of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Ann Pharmacother. 2004;38:1747-9.
Mantena R. Managing the costs of injectable therapies: do you have the right gameplan?
Leary RS and Farley D. The future of APCs: a look at Medicare's 2005 changes and industry trends. Healthcare Financial Management. 2005;Mar:44-7
Variability And Growth In Spending For Outpatient Specialty Pharmaceuticals Mullins et al. Health Affairs. 2005; 24:1117-27.
New Medicare Part D Prescription Drug Information: Preparing for the Change. Woelfel JA. Pharmacists' Letter. July 2005